TELL ME MORE
ABOUT THIS CLINICAL TRIAL for MIGRAINES in CHILDREN
This is an Double Blind, Placebo Controlled Phase 3 Study of an Investigational Medicine for Migraine Patients Ages 6 – 17 Years.
Clinical Trial for Migraines in Children
Study Location(s): Owensboro and Bowling Green Kentucky, Evansville Indiana
Migraine is one of the most common neurological conditions in pediatrics with a prevalence of approximately 8% in children under 20 years of age. Migraine occurs more frequently in adolescents compared with the younger pediatric age groups. There is a significant increase in migraine incidence in females after puberty. In children and adolescents, headache and migraine can result in missed school days, poorer academic performance and a negative impact on quality of life. There are few treatments approved for the acute treatment of migraine in adolescents, and only 1 treatment approved for children aged 6 to 11 years. Thus, there remains a significant unmet need for the acute treatment of migraine in children and adolescents. This is a double-blind, placebo-controlled, phase 3 study of an investigational medicine for acute migraine in children ages 6 – 17. Patient volunteers will have an option to enter a 52 week long-term open-label extension study. Click here for more information on living with pediatric migraine.
There is no cost to participate. Volunteers receive free investigational medicine and follow-up care. No insurance needed. Time and travel reimburrsement up to $550 may be available.
View More Studies
| Condition | Location | Status | Age Range | Sex | Max Compensation | |
|---|---|---|---|---|---|---|
| ADHD A Long-term active comparitor and dose optimization study to evaluatate safety and efficacy of a non-stimulat medication | Owensboro | Coming Soon | 6 - 17 | $1150 | Request Info | |
| ADHD A randomized, double-blind, multicenter, placebo-controlled study to evaluatate efficacy and safety of an investigational medicine in preschool-age children | Bowling Green Evansville Owensboro | Coming Soon | 4 - 5 | $400 | Request Info | |
| ASTHMA Safety and Efficacy Study of a Fixed Dose Combination (FDC) in Subjects With Asthma | Evansville | Recruiting | 5 - 17 | $800 | Request Info | |
| COMMON WARTS Efficacy, Safety and Tolerability Study in Children and Adults with Common Warts | Evansville | Coming Soon | 2+ | $350 | Request Info | |
| DIABETES (T2DM) Active Comparitor Study of a Dual Action versus Single Action Investigational Medicine on Glucose Control and Cardiovascular Events in Adults Age 40+ living with Type 2 Diabetes and CV Risk Factors | BowlingGreen Owensboro | Coming Soon | 40 + | $600/year (long-term study could last up to 5 years) | Request Info | |
| IBD - CROHN'S DISEASE A Safety and efficacy, placebo-controlled and active-controled comparison study for patients with moderate to severe Crohn's Disease | Owensboro Evansville | Recruiting | 18 - 80 | $3200 | Request Info | |
| IBD - ULCERATIVE COLITIS A Safety and efficacy, placebo-controlled and active-controled comparison study for patients with moderate to severe Ulcerative Colitis | Evansville | Recruiting | 18 - 80 | $1100 | Request Info | |
| IBS- CONSTIPATION A Efficacy and safety, placebo-controlled study for patients with constipation due to irritable bowel syndrome | BowlingGreen Evansville | Recruiting | 6 - 17 | $350 | Request Info | |
| INFANT FORMULA Comparison Study | BowlingGreen Evansville Owensboro | Recruiting | Newborns | Variable up to $150, + formula and diapers | Request Info | |
| INFANT VACCINE Comparison Study between two meningococcal vaccines | Evansville | Recruiting | Newborns | Variable up to $400 | Request Info | |
| LUPUS ERYTHEMATOSUS A Safety, efficacy and dose ranging comparison study for patients with moderate to severely active Systemic Lupus Erythematosus | Evansville | Recruiting | 18 - 65 | $750 | Request Info | |
| MIGRAINES in CHILDREN A Double Blind, Placebo Controlled Study of an Investigational Medicine for Pediatric Migraines | BowlingGreen Owensboro Evansville | Coming Soon | 6 - 17 | $200/$350 | Request Info | |
| PRURITUS (CHRONIC ITCH) An efficacy and safety study for the treatment of chronic itch in adult subjects with atopic dermatitis | Owensboro | Coming Soon | 18 - 75 | $600 | Request Info | |
| PSORIATIC ARTHRITIS (PsA) A Phase 4 Clincial Trial for Psoriatic Arthritis in Adults. This is a compartive study in treatment-naive adults with active Psoriatic Arthritis | Evansville | Coming Soon | 18+ | $900 | Request Info | |